GlassScriptPhysician profile
Salman M Azam
NPI 1962616888
$199,924.13
in general payments reported to CMS, 2019-2025
32 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $5,834 · 2021: $32K · 2022: $37K · 2023: $51K · 2024: $37K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $91K · Food and Beverage: $9,983 · Travel and Lodging: $5,329 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,137.50 |
| Food and Beverage | $9,983.35 |
| Travel and Lodging | $5,328.80 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $189,731.27 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $2,995.89 | 2019-2025 | Avvigo Guidance System, Rotapro, Sentinel |
| Abbott Laboratories | $1,681.17 | 2020-2025 | Mitraclip, Triclip, Navitor |
| Medtronic, INC. | $1,270.35 | 2021-2025 | Micra, Na, Epsila Ev |
| Novartis Pharmaceuticals Corporation | $598.00 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $551.30 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $494.53 | 2019-2024 | Xarelto |
| Pfizer INC. | $437.45 | 2019-2025 | |
| Medtronic Vascular, INC. | $344.85 | 2019-2020 | |
| Abiomed | $221.60 | 2022-2025 | Impella |
| Philips North America LLC | $215.43 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.97 | 2023-2025 | Jardiance |
| Amgen INC. | $142.09 | 2019-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $138.07 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $108.14 | 2022-2025 | Eliquis, Camzyos |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $102.34 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $95.72 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $71.34 | 2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $67.99 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $53.52 | 2023 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $52.71 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $45.09 | 2024-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $42.90 | 2020-2024 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $39.06 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $37.29 | 2025 | Nexletol |
| Irhythm Technologies, INC. | $36.06 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $33.34 | 2021-2023 | Ozempic |
| Altathera Pharmaceuticals LLC | $29.54 | 2025 | Sotalol Hydrochloride |
| Heartflow, INC. | $28.07 | 2025 | |
| Inspire Medical Systems, INC. | $26.83 | 2025 | Inspire |
| Ge Healthcare | $22.62 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $18.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Azam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.